In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines

In order to develop peptide agents with reduced length and enhanced tumoricidal activity, we have designed gaegurin 6 (GGN6) derivatives through deletions and/or substitutions of amino acids. The deletion of hydrophobic amino terminal region completely abolished antitumor activity whereas the deletion of carboxy terminal region had little influence on antitumor activity. Antitumor activity of the PTP peptides did not correlate with antibacterial activity. PTP7, the most potent derivative, was found to have comparable antitumor activity to GGN6 in spite of reduced number of amino acids which is about half the size of gaegurin 6; furthermore, it showed little cytotoxicity on PBMCs and RBCs. GGN6 and PTP7 also showed equivalent cytotoxicity against drug sensitive (MCF-7) and multidrug-resistant cell lines (MCF-7/DOX). Plasma membrane blebbing and DNA fragmentation of peptide-treated tumor cells indicated that the peptides could induce apoptosis in tumor cells. These results suggest that GGN6 and its derivatives can be developed as new anticancer agents and may provide a new strategy for overcoming MDR which is a major problem in cancer therapy.

[1]  J. Mai,et al.  A proapoptotic peptide for the treatment of solid tumors. , 2001, Cancer research.

[2]  H. Wenschuh,et al.  Proline at position 14 of alamethicin is essential for hemolytic activity, catecholamine secretion from chromaffin cells and enhanced metabolic activity in endothelial cells. , 1998, Biochimica et biophysica acta.

[3]  K. Gelmon,et al.  In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. , 2000, Anti-cancer drug design.

[4]  Paolo Bernardi,et al.  BMAP-28, an Antibiotic Peptide of Innate Immunity, Induces Cell Death through Opening of the Mitochondrial Permeability Transition Pore , 2002, Molecular and Cellular Biology.

[5]  K. White,et al.  In vitro cytocidal effect of lytic peptides on several transformed mammalian cell lines. , 1989, Peptide research.

[6]  J. L. Biedler,et al.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. , 1970, Cancer research.

[7]  J. Barker,et al.  Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Sharom,et al.  Interaction of the P-glycoprotein Multidrug Transporter with Peptides and Ionophores (*) , 1995, The Journal of Biological Chemistry.

[9]  D. Tosteson,et al.  Melittin lysis of red cells , 2005, The Journal of Membrane Biology.

[10]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[11]  Byong-Seok Choi,et al.  Antimicrobial activity and conformation of gaegurin-6 amide and its analogs , 1998, Peptides.

[12]  Beni M. Sahai,et al.  Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes , 1989, Nature.

[13]  J. Hoffmann,et al.  Innate immunity of insects. , 1995, Current opinion in immunology.

[14]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[15]  A. Mor,et al.  Peptides as weapons against microorganisms in the chemical defense system of vertebrates. , 1995, Annual review of microbiology.

[16]  D. Eisenberg,et al.  Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.

[17]  V. Ling,et al.  P-glycoprotein and tumor progression. , 1994, Journal of the National Cancer Institute.

[18]  Alessandro Tossi,et al.  Amphipathic α helical antimicrobial peptides. , 2001 .

[19]  D. Barra,et al.  Amphibian skin: a promising resource for antimicrobial peptides. , 1995, Trends in biotechnology.

[20]  A. Gazdar,et al.  Antitumor activity of magainin analogues against human lung cancer cell lines. , 1992, Cancer research.

[21]  D. Barra,et al.  Temporins, antimicrobial peptides from the European red frog Rana temporaria. , 1996, European journal of biochemistry.

[22]  J. Gabay,et al.  Ubiquitous natural antibiotics. , 1994, Science.

[23]  Erkki Ruoslahti,et al.  Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.

[24]  Jiang Hong,et al.  A Repertoire of Novel Antibacterial Diastereomeric Peptides with Selective Cytolytic Activity* , 1997, The Journal of Biological Chemistry.

[25]  B. Merrifield,et al.  Solid phase synthesis , 1985, Science.

[26]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[27]  J. Jung,et al.  Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. , 1994, Biochemical and biophysical research communications.

[28]  Y. Chen,et al.  RGD-Tachyplesin inhibits tumor growth. , 2001, Cancer research.